Literature DB >> 15246217

Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong.

Man-Fung Yuen1, Erwin Sablon, Yasuhito Tanaka, Takanobu Kato, Masashi Mizokami, Joke Doutreloigne, He-Jun Yuan, Danny Ka-Ho Wong, Siu-Man Sum, Ching-Lung Lai.   

Abstract

BACKGROUND/AIMS: We conducted a population study to document the prevalence of hepatitis B virus (HBV) genotypes in Hong Kong.
METHODS: HBV genotypes, core promoter (CP) and precore mutations were determined in 776 asymptomatic patients.
RESULTS: 92.6% patients had single genotype [B (32.5%), C (62.5%)]. 99.1% of genotype B was subtype Ba. Patients with age <50 years had a lower prevalence of genotype B than patients with age >51 years (32.5% vs. 41%, respectively, P=0.028). Compared to patients with genotype C, patients with genotype B had a higher cumulative rate (P=0.018) and younger age (40.1 vs. 34.2 years, respectively, P=0.018) of HBeAg seroconversion. There were no differences in the HBV DNA levels between patients with genotypes B and C, and with wild-type and mutants of CP and precore regions. By multivariate analysis, patients with genotype C and with CP mutations had higher alanine aminotransferase (ALT) levels.
CONCLUSIONS: B and C were the two most common HBV genotypes in Hong Kong. The former had a higher chance of earlier HBeAg seroconversion and lower ALT levels. The prevalence of genotype B was lower in patients with age <50, probably related to influx of immigrants from China since 1949.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246217     DOI: 10.1016/j.jhep.2004.03.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

1.  Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients.

Authors:  Hai-Ying Lu; Li-Wei Zhuang; Yan-Yan Yu; Chong-Wen Si; Jun Li; Jian-Jun Zhang; Zheng Zeng; Xin-Yue Chen; Zhong-Hou Han; Yong Chen
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 2.  Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance.

Authors:  Catherine Mn Croagh; Paul V Desmond; Sally J Bell
Journal:  World J Hepatol       Date:  2015-03-27

3.  Identification of Novel Recombinant Forms of Hepatitis B Virus Generated from Genotypes Ae and G in HIV-1-Positive Japanese Men Who Have Sex with Men.

Authors:  Yoko Kojima; Takuya Kawahata; Haruyo Mori; Keiichi Furubayashi; Yasushi Taniguchi; Ichiro Itoda; Jun Komano
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-04       Impact factor: 2.205

4.  Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study.

Authors:  Syria Laperche; Vincent Thibault; Françoise Bouchardeau; Sophie Alain; Sandrine Castelain; Michelle Gassin; Marie Gueudin; Philippe Halfon; Sylvie Larrat; Françoise Lunel; Michèle Martinot-Peignoux; Bernard Mercier; Jean-Michel Pawlotsky; Bruno Pozzetto; Anne-Marie Roque-Afonso; Françoise Roudot-Thoraval; Karine Sauné; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

5.  Clinical characteristics and distribution of hepatitis B virus genotypes in Guangxi Zhuang population.

Authors:  Zhong-Min Huang; Qi-Wen Huang; Ya-Qin Qin; Chun-He Huang; Hou-Ji Qin; Yiao-Nan Zhou; Xiang Xu; Chun-Lei Lu
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

6.  Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma.

Authors:  H Lyu; D Lee; Y-H Chung; J A Kim; J-H Lee; Y-J Jin; W Park; P Mathews; E Jaffee; L Zheng; E Yu; Y J Lee
Journal:  J Viral Hepat       Date:  2012-08-16       Impact factor: 3.728

7.  Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.

Authors:  Danbi Lee; Heather Lyu; Young-Hwa Chung; Jeong A Kim; Priya Mathews; Elizabeth Jaffee; Lei Zheng; Eunsil Yu; Young Joo Lee; Soo Hyung Ryu
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

8.  Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients.

Authors:  Hai-Ying Lu; Li-Wei Zhuang; Yan-Yan Yu; Hadad Ivan; Chong-Wen Si; Zheng Zeng; Jun Li; Dong-Ming Hou; Xin-Yue Chen; Zhong-Hou Han; Yong Chen
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

9.  Detection of hepatitis B virus genotypes using oligonucleotide chip among hepatitis B virus carriers in Eastern China.

Authors:  Xiang-Rong Tang; Ji-Shen Zhang; Hui Zhao; Yu-Hua Gong; Yong-Zhong Wang; Jian-Long Zhao
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

10.  Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.

Authors:  X Ren; Z Xu; Y Liu; X Li; S Bai; N Ding; Y Zhong; L Wang; P Mao; F Zoulim; D Xu
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.